Relay Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
37.20
|
|
Average Rating
|
4.09
|
|
# Strong Buys
|
5
|
|
# Buys
|
4
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.71
|
-0.76
|
-0.05
|
-7.04%
|
|
2022-06-30
|
-0.63
|
-0.71
|
-0.08
|
-12.70%
|
|
2022-03-31
|
-0.62
|
-0.57
|
0.05
|
8.06%
|
|
2021-12-31
|
-0.58
|
-0.62
|
-0.04
|
-6.90%
|
|
2021-09-30
|
-0.64
|
-0.66
|
-0.02
|
-3.13%
|
|
2021-06-30
|
-0.46
|
-2.10
|
-1.64
|
-356.52%
|
|
2021-03-31
|
-0.48
|
-0.47
|
0.01
|
2.08%
|
|
2020-12-31
|
0.17
|
0.70
|
0.53
|
311.76%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.04
|
|
2021-12-31
|
-3.85
|
|
2020-12-31
|
-8.75
|